GI & Endoscopy

FDA approves oral treatment for opioid-induced constipation

The FDA has approved the oral treatment for opioid-induced constipation naloxegol (Movantik), according to a Gastroenterology & Endoscopy News report.

Carrie Pallardy

Wednesday, September 17th, 2014

Movantik is designed for adults with chronic non-cancer pain. The drug is a peripherally acting mu-opiod-receptor antagonist used to decrease the constipation side effect of opioids, according to the report.

More articles on gastroenterology:
19 things to know about GI compensation & satisfaction in 2014
AGA releases new tool for Crohn’s disease treatment
How has the Obama presidency affected the field of GI?

Next Up in GI & Endoscopy

5 GI leaders honored in 2025

In 2025, national gastroenterology and hepatology organizations recognized physicians whose work is advancing digestive disease research, clinical care, education and…

By: Sophie Eydis
19 hours ago
The 5 highest-paid gastroenterologists in Miami

The highest-paid gastroenterologist in Miami earns $979,100 per year, according to Medscape’s salary reporter tool. Here is what the five…

By: Cameron Cortigiano
Yesterday
Gastroenterologist named chair of MetroHealth department of medicine

Cleveland-based MetroHealth System has appointed John Vargo, MD, as chair of its department of medicine, according to a Dec. 15…

By: Patsy Newitt
Yesterday

Comments are closed.

Stop Buying Recommendations. Start Buying Results: Why more hospitals are replacing traditional consulting with managed partnerships

Next Up in GI & Endoscopy

5 GI leaders honored in 2025

The 5 highest-paid gastroenterologists in Miami

Gastroenterologist named chair of MetroHealth department of medicine

Join the 40,000+ ASC leaders who start their day with Becker's